Intuitive Surgical designs and manufactures robotic-assisted surgical systems, most notably the da Vinci platform used for minimally invasive soft-tissue surgery and the Ion system for robotic bronchoscopy lung biopsies. The company earns recurring revenue from instruments, accessories, and service contracts tied to a large installed base of robotic systems used across urology, gynecology, general surgery, and thoracic procedures.

ISRG consistently appears in robotics signal pipelines due to its dominant patent portfolio in surgical robotics, deep clinical research citation footprint, and ongoing rollout of its next-generation da Vinci 5 platform with enhanced computing power and force feedback. Continued double-digit procedure growth, expanding global installed base, and partnerships with major health systems reinforce its position as the benchmark commercial player in medical robotics.